Company / Total Assets
Fulgent Genetics, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.2B
FY2025
5-year range
$1.2B / $1.4B
FY2021-FY2025
Trend
-0.5%
vs FY2024
Sector context
#107 of 161
Health Care
What the data says
At $1.2B, Fulgent Genetics, Inc.'s total assets ranks #107 of 161 in the Health Care sector. Total Assets has declined for 3 consecutive years, from $1.4B in FY2022 to $1.2B in FY2025.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +11.6%.
Remained stable around $1.2B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -4.3%
- 5-Year CAGR
- +11.6%
- 10-Year CAGR
- -
Sector benchmark
#107 of 161 in Health CareTop 66% of 161This company $1.2B Sector average $14.8B
▼
-91.8% below sector average
Key checks
Key Insights
- Fulgent Genetics, Inc.'s total assets has declined for 3 consecutive years.
- 5-year CAGR of +11.6%, indicating consistent growth.
- In FY2025, total assets decreased 0.5% year-over-year.
- Ranks #107 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | -0.5% |
| FY2024 | $1.2B | -1.2% |
| FY2023 | $1.2B | -10.9% |
| FY2022 | $1.4B | +8.4% |
| FY2021 | $1.3B | +82.6% |
| FY2020 | $700.5M | +689.2% |
| FY2019 | $88.8M | +64.7% |
| FY2018 | $53.9M | -5.7% |
| FY2017 | $57.2M | -1.5% |
| FY2016 | $58.0M | +895.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026